Over the past century, Kuwait has developed a health system encompassing all six components the World Health Organization (WHO) identifies as essential: service delivery, health workforce, health information systems, medical products and technologies, financing, and leadership and governance (1). National data from 2011 to 2022 show substantial expansion and resilience amid global shocks (2), and Kuwait compares favourably on key outcomes, with a life expectancy of approximately 80 years and an under-five mortality rate of 8.56 per 1,000 live births (3). The central policy question is therefore not whether Kuwait has capacity, but how that capacity is governed, measured and directed towards value.In this article, value describes how a health system's resources and capacity achieve WHO's framework goals: improved, equitable health, responsiveness, social and financial protection, and efficiency (1). This definition is broader than the economic perspective of health outcomes achieved per unit of cost (4), and aligns with the European Expert Panel's multidimensional concept of value, which encompasses personal, technical, allocative, and societal dimensions (5). According to the WHO framework, building blocks are system inputs, while goals are outcomes. Capacity is necessary but not enough for value, which depends on directing capacity through funding, provider payments, and results measurement. Assessing value needs indicators for each goal, as in Table 1. Kuwait can report some indicators at an aggregate level, but most require linked, case-level data, which this article examines.Several of Kuwait's neighbours have begun to separate the financing, provision and regulation of care (6)(7)(8). In our view, Kuwait's key issue is not which institutional model it adopts but whether the model can measure cost, need, and outcomes at the patient level. Structural reform without adequate analytic capacity risks changing only the system's architecture without improving results. Three gaps remain: limited data infrastructure for decisions, a service mix still focused on curative care, and a budget process not linked to cost or outcome data. This article examines Kuwait's health system through the WHO health system framework and proposes a reform agenda. First, it argues that Kuwait should develop case-level data alongside institutional reform to ensure new structures are accountable. Second, drawing on recent reforms in Gulf Cooperation Council (GCC) countries, it organises reform options into three interconnected paths: data, financing, and governance.Healthcare is organised across six regions in a three-tier system linking primary care with general and tertiary hospitals. From 2011 to 2022, the number of hospitals increased from 14 to 20, beds rose by roughly 30% to 8,735, and 19 primary health centres were added (2). The challenge is therefore one of orientation rather than volume. At the time of the 2018 health system review, about 85% of expenditure remained curative (9), although non-communicable diseases (NCDs) accounted for around 80% of disability-adjusted life years and nearly one in five adults dies from an NCD before age 70 (10). In our view, better value therefore requires stronger primary care, screening and longitudinal NCD management (11).Kuwait has expanded its national clinical workforce: Kuwaitis now make up about 75% of dentists and 41% of physicians, but only 5% of nurses (2). However, national recruitment strategies have largely focused on traditional patient-facing cadres, overlooking the specialised human capital required to govern a modern health system. The 2018 health system review found shortages in health informatics, biostatistics, and health economics, and noted that these disciplines lack defined civil service career pathways (9). In our assessment, a specialised analytical workforce is essential; without it, digital infrastructure serves administrative rather than analytical objectives.Kuwait has digitised much of its primary care, implementing electronic records and ICD coding (9). However, the gap is not in data collection but in data aggregation: a centralised system that consolidates primary care, hospital, and private-sector records into a linked, case-level resource. We argue that such a system would support routine policy analysis, replacing the current fragmented, facility-specific records and occasional studies (9). Accurate, linked data is crucial for purchasing, premium setting, costing, prevention, and accountability. When such data exists, it is insightful: analysis of 4.4 million claims from the AFYA scheme for retirees revealed that routinely collected administrative records can identify variations in coverage definitions, coding practices, and service rejection patterns (12). However, such analyses are still uncommon and not yet standard practice in planning.Registration, licensing, and quality assurance are well established; essential medicines are broadly accessible, and Kuwait purchases part of its requirements collectively through the GCC secretariat, with the remainder tendered nationally and distributed via Central Medical Stores (9). Although Kuwait already purchases generic medicines, the 2018 review found no formal national generics policy to guide substitution, prescribing, or procurement decisions, a gap that may have contributed to growth in the Ministry of Health (MOH) budget (9). Therefore, we argue that reducing this exposure requires either substituting more systematically with generics or building domestic manufacturing capacity, both of which are financing questions as much as procurement ones.Kuwait performs strongly in financial protection: government sources account for 88% of current health expenditure, the highest share in the GCC, while out-of-pocket spending stands at 10% ( 13). Yet allocation remains input-based. Providers receive block budgets rather than payments adjusted for risk, activity or outcomes, and full costing...